Protein Kinase D Regulates Cofilin Activity through p21-activated Kinase 4

被引:61
|
作者
Spratley, Samantha J. [1 ]
Bastea, Ligia I. [1 ]
Doeppler, Heike [1 ]
Mizuno, Kensaku [2 ]
Storz, Peter [1 ]
机构
[1] Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, Jacksonville, FL 32224 USA
[2] Tohoku Univ, Dept Biomol Sci, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan
基金
美国国家卫生研究院;
关键词
CANCER-CELL-MIGRATION; LIM-KINASE; ACTIN REORGANIZATION; PHOSPHATASE SLINGSHOT; LEADING-EDGE; PHOSPHORYLATION; ACTIVATION; INVASION; MOTILITY; DYNAMICS;
D O I
10.1074/jbc.M111.259424
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dynamic reorganization of the actin cytoskeleton at the leading edge is required for directed cell migration. Cofilin, a small actin-binding protein with F-actin severing activities, is a key enzyme initiating such actin remodeling processes. Cofilin activity is tightly regulated by phosphorylation and dephosphorylation events that are mediated by LIM kinase (LIMK) and the phosphatase slingshot (SSH), respectively. Protein kinase D (PKD) is a serine/threonine kinase that inhibits actin-driven directed cell migration by phosphorylation and inactivation of SSH. Here, we show that PKD can also regulate LIMK through direct phosphorylation and activation of its upstream kinase p21-activated kinase 4 (PAK4). Therefore, active PKD increases the net amount of phosphorylated inactive cofilin in cells through both pathways. The regulation of cofilin activity at multiple levels may explain the inhibitory effects of PKD on barbed end formation as well as on directed cell migration.
引用
收藏
页码:34254 / 34261
页数:8
相关论文
共 50 条
  • [31] p21-activated kinase signaling in breast cancer
    Anupama E Gururaj
    Suresh K Rayala
    Rakesh Kumar
    Breast Cancer Research, 7
  • [32] Increased expression of p21-activated kinase in adenomyosis
    Kim, So Ra
    Kim, Sung Hoon
    Lee, Hoi Woul
    Chae, Hee Dong
    Kim, Chung-Hoon
    Kang, Byung Moon
    FERTILITY AND STERILITY, 2010, 94 (03) : 1125 - 1128
  • [33] Interaction of paxillin with p21-activated kinase (PAK)
    Hashimoto, S
    Tsubouchi, A
    Mazaki, Y
    Sabe, H
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 172A - 173A
  • [34] P21-activated kinase 1 and breast cancer
    Rakesh Kumar
    中华乳腺病杂志(电子版), 2010, 4 (05) : 544 - 553
  • [35] P21-activated kinase is required for mitotic progression and regulates Plk1
    B Maroto
    M B Ye
    K von Lohneysen
    A Schnelzer
    U G Knaus
    Oncogene, 2008, 27 : 4900 - 4908
  • [36] Activation of p21-activated kinase (γ-PAK) by sphingosine
    Tuazon, PT
    Roig, J
    Gatti, A
    Traugh, JA
    FASEB JOURNAL, 1999, 13 (07): : A1490 - A1490
  • [37] Phosphorylation of RhoGDI by p21-activated kinase 1
    DerMardirossian, CM
    Bokoch, GM
    METHODS IN ENZYMOLOGY, VOL 406, REGULATORS AND EFFECTORS OF SMALL GTPASES: RHO FAMILY, 2006, 406 : 80 - 90
  • [38] The mechanism of p21-activated kinase 2 autoactivation
    Wu, H
    Wang, ZX
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (43) : 41768 - 41778
  • [39] P21-activated kinase in inflammatory and cardiovascular disease
    Taglieri, Domenico M.
    Ushio-Fukai, Masuko
    Monasky, Michelle M.
    CELLULAR SIGNALLING, 2014, 26 (09) : 2060 - 2069
  • [40] p21-Activated kinase inhibitors: a patent review
    Crawford, James J.
    Hoeflich, Klaus P.
    Rudolph, Joachim
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2012, 22 (03) : 293 - 310